COO: The Cooper Companies, Inc. Long-Term Debt Volume

Symbol and logo of brand CooperSurgical (COO)

Production stability in the US and UK supports the stock dynamics of The Cooper Companies (COO), as reflected in the organization's long-term financial debt levels. The value of 1.95 describes the current status of this metric. Growth is driven by low demand elasticity for vision correction and the uniqueness of materials. High patient loyalty and FDA approvals solidify the company's position in the women's health and ophthalmology niches.

COO (coopercos.com) Company Long-Term Debt history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company CooperVision (COO)

- price and consensus price forecast:
Stock Quotes coopercos.com|COO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization CooperCompanies|COO - Enterprise Value
- book capitalization data:
Book Value per Share CooperCompanies|COO - Company Book Value|Market Value to Book Value Ratio coopercos.com|COO - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient The Cooper Companies|COO - Long-Term Debt to Equity Ratio|Current Liabilities to Equity CooperSurgical|COO - Company Aggregate Debts|Debts to Book Value CooperCompanies|COO - Company Long-Term Debts|Company Short-Term Indebtedness CooperCompanies
Fundamental valuation:COO (coopercos.com)
Mass-produced product of The Cooper Companies, Inc.

Long-term debt measures the total obligations with a maturity of more than one year, determining financial stability and the cost of capital. The dynamics of a company's long-term debt reflect the balance between credit load and investment potential. This metric is calculated by aggregating long-term bonds and loans, allowing for an assessment of default risk. For The Cooper Companies (COO), such resources are critical when implementing its expansion strategy in the ophthalmology and women's health segments.

Competitor analysis

Company Long-Term Liabilities bostonscientific.com BSX|Company Long-Term Debts EW (Edwards Lifesciences Corporation)|RMD - Long-Term Debt Volume|PODD: Company Long-Term Debts|ZBH (Zimmer Biomet Holdings, Inc.) - Company Long-Term Debts|Company Long-Term Debt Align Technology, Inc.|Company Long-Term Debt globusmedical.com|TMDX (TransMedics Organ Care System) - Company Long-Term Debts|Long-Term Debt Volume Alphatec Holdings ATEC|Artivion Inc (AORT) - Company Long-Term Liabilities|Long-Term Liabilities Enovis Inc. ENOV|IART (Integra LifeSciences) - Company Long-Term Debts|ESTA - Long-Term Debt|Company Long-Term Debts Beta Bionics|Company Long-Term Indebtedness IRADIMED Corp|EMBC - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TNDM|Company Long-Term Debt AXGN (AxoGen, Inc.)|Company Long-Term Liabilities si-bone.com (SIBN)|OFIX: Company Long-Term Debts|Long-Term Debt Bioventus Inc BVS|OrthoPediatrics Inc. (KIDS) - Company Long-Term Debts|TMCI - Company Long-Term Indebtedness|Strata Critical Medical Inc - Company Long-Term Debts|carlsmed.com (CARL) - Long-Term Debt Volume|Company Long-Term Debts RXST|Company Long-Term Liabilities ClearPoint|Company Long-Term Debts STXS|Company Long-Term Debts STIM (Neuronetics, Inc)|Company Long-Term Debt Sight Sciences, Inc. SGHT|OBIO - Company Long-Term Debt|Company Long-Term Liabilities Anika (ANIK)|NSPR - Company Long-Term Loans and Borrowings|Company Long-Term Debts ZJYL|VANI (Vivani Medical) - Long-Term Debt|Xtant Medical Holdings, Inc. - Company Long-Term Debt|Long-Term Indebtedness n1mtc.com (NMTC)|Company Long-Term Liabilities MODD|Company Long-Term Debts Myomo Inc. (MYO)|Company Long-Term Debts COCH|Vivos Therapeutics Inc - Long-Term Debt Volume|Company Long-Term Debt enVVeno Medical|SINT: Long-Term Liabilities|TNON (Tenon Medical) - Company Long-Term Debt|ReWalk Robotics (LFWD) - Company Long-Term Liabilities|Company Long-Term Debts AMIX (Autonomix Medical Inc.)|Long-Term Debt IVF|Company Long-Term Debt Bone Biologics BBLG|Company Long-Term Indebtedness axonics.com AXNX|Company Long-Term Liabilities BIOLASE (BIOL)|DYNT - Amount of Long-Term Liabilities|Company Long-Term Liabilities Paragon 28 Corp FNA|INVO - Amount of Long-Term Liabilities